Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Leukotriene C4 and Serine

supplement:

Serine

Research Papers that Mention the Interaction

In contrast, verlukast (20-200 nM) failed to antagonize contractions of GPT induced by leukotriene C4 in the presence of 45 mM L-serine borate.
Canadian journal of physiology and pharmacology  •  1991  |  View Paper
L-Serine borate complex, 45 mM, … the degradation of LTC4 to LTD4 by the enzyme gamma-glutamyl transpeptidase, in paired airway segments (adjacent segments from the same branch), produced a …-fold) of shift to the right of the dose-response curve and reduction of the maximum response to LTC4.
The Journal of pharmacology and experimental therapeutics  •  1986  |  View Paper
Inhibition of LTC4 bioconversion to LTD4 by pretreatment with L-serine (100 mumol/L) prevented the LTC4-induced increase in leukocyte rolling flux and the LTC4-induced reduction in leukocyte rolling velocity.
Circulation research  •  1995  |  View Paper
In separate experiments, responses to LTC4 were also reduced by approximately 50% if LTC4 conversion to LTD4 and LTE4 was first prevented by L-serine borate (45 mM) in combination with L-cysteine (10 mM).
The American journal of physiology  •  1993  |  View Paper
L-Serine borate (45 mM), an inhibitor of gamma-glutamyl …, shifted the dose-response curve of LTC4 to the left by 161-fold, and L-cysteine (6 mM), an inhibitor of aminopeptidase, shifted … dose-response curves of LTC4 and LTD4 to the left by 67- and 23-fold, respectively.
Canadian journal of physiology and pharmacology  •  1991  |  View Paper
LTC4 was significantly more potent in the presence of L-serine borate , an inhibitor of gamma-glutamyl transpeptidase, than in its absence, raising the possibility of significant bioconversion of LTC4 by the bullfrog heart.
Biomedica biochimica acta  •  1988  |  View Paper
L-Serine borate (45 mM) enhanced the contractile activity of LTC4 without altering the response to LTD4.
The bioconversion of [3H]LTC4 was blocked by L-serine borate in a concentration-related manner (IC50 = 3.4 +/- 0.5 mM, mean +/- S.E.M., n = 3) and the formation of LTE4 was blocked by L-cysteine (10 mM).
The Journal of pharmacology and experimental therapeutics  •  1984  |  View Paper
L-Serine borate (45 mM) increased selectively the contractile activity of LTC4.
L-Serine borate , an inhibitor of gamma-glutamyl transpeptidase prevents the conversion of LTC4 to LTD4.
The Journal of pharmacology and experimental therapeutics  •  1984  |  View Paper